Treatment characteristics in subgroup of participants receiving oxygen therapy (n = 190) by mortality outcome
| Treatment | No. (%) of patients | p value | |
|---|---|---|---|
| Alive n = 121 | Deceased n = 69 | ||
| Dexamethasone | 88 (72.7) | 48 (69.6) | 0.6 |
| Remdesivir | 50 (41.3) | 18 (26.1) | 0.04 |
| Tocilizumab | 23 (19.0) | 11 (15.9) | 0.6 |
| Antibiotics (any) | 97 (80.2) | 48 (69.6) | 0.1 |
| Reduction in calcineurin inhibitor (any) | 31 (25.6) | 18 (26.1) | 0.9 |
| Reduction in antimetabolite (any) | 86 (71.1) | 44 (63.8) | 0.3 |